Spiro Rombotis
2012
In 2012, Spiro Rombotis earned a total compensation of $659.8K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $126,250 |
|---|---|
| Salary | $505,000 |
| Other | $28,562 |
| Total | $659,812 |
Rombotis received $505K in salary, accounting for 77% of the total pay in 2012.
Rombotis also received $126.3K in bonus and $28.6K in other compensation.
Rankings
In 2012, Spiro Rombotis' compensation ranked 7,779th out of 11,487 executives tracked by ExecPay. In other words, Rombotis earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,779 out of 11,487 | 32nd |
Division Manufacturing | 2,797 out of 4,253 | 34th |
Major group Chemicals And Allied Products | 731 out of 1,198 | 39th |
Industry group Drugs | 518 out of 920 | 44th |
Industry Pharmaceutical Preparations | 408 out of 700 | 42nd |
Source: SEC filing on April 2, 2014.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2012.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020